Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy

Hepatogastroenterology

Bixia Liu, Jieer Ying, Cong Luo et al. · Hepatogastroenterology · 2012 · 1.3K citations

Medicine, Molecular Biology, Oncology +17

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity

Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen et al. · Molecular Cancer Therapeutics · 2008 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +13

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

Takao Kanzawa, Isabelle M. Germano, Tadashi Komata et al. · Cell Death and Differentiation · 2004 · 984 citations

Life Sciences, Oncology, Pharmacology +11

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

Violeta Serra, Ben Markman, Maurizio Scaltriti et al. · Cancer Research · 2008 · 796 citations · Full text

Medicine, Oncology, Pharmacology +16

Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition

Shinji Saiki, Yukiko Sasazawa, Yoko Imamichi et al. · Autophagy · 2011 · 419 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17